Allient Stock Forecast for 2023 - 2025 - 2030
Updated on 05/03/2024
Allient Stock Forecast and Price Target
Year-long price target forecasts from three prominent analysts have recently been released for Allient, with an average price target of $41.00. This potential gain of 37.03 percent from the previous closing price in May, 2024 is calculated on a high forecast of $42.00 and a low estimate of $40.00. Even if you're not interested in ALNT stock, you may be interested in its competitors.
37.03% Upside
Allient Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Allient's Price has decreased from $25.16 to $0.00 – a 100.00% drop. In the next year, analysts believe that Fair Value will reach $43.53 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SIE Stock Forecast | Siemens | Outperform |
10
|
175.20€ | Buy/Sell | 178.14€ | 11.59% |
| ETN Stock Forecast | Eaton | Outperform |
13
|
$315.27 | Buy/Sell | $246.22 | 2.13% |
| PH Stock Forecast | Parker-Hannifin Corp | Outperform |
10
|
$530.68 | Buy/Sell | $548.76 | 13.06% |
| AME Stock Forecast | AMETEK | Outperform |
10
|
$163.34 | Buy/Sell | $180.64 | 19.38% |
| CAH Stock Forecast | Cardinal Health Inc | Hold |
13
|
$102.98 | Buy/Sell | $108.07 | 11.67% |
Allient Revenue Forecast for 2023 - 2025 - 2030
Allient's Revenue has seen impressive growth In the last three years, rising from $366.69M to $578.63M – a growth of 57.80%. In the next year, analysts believe that Revenue will reach $589.89M – an increase of 1.95%. For the next seven years, the forecast is for Revenue to grow by 18.19%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 6594 Stock Forecast | Nidec | Outperform |
18
|
¥5.79k | Buy/Sell | ¥8.31k | 37.26% |
| WWD Stock Forecast | Woodward | Outperform |
18
|
$167.99 | Buy/Sell | $135.80 | 1.79% |
| NOVT Stock Forecast | Novanta | Outperform |
14
|
$159.65 | Buy/Sell | $156.00 | 11.81% |
.jpg)
Allient Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Allient's Dividend per Share has grown by 50.00%, rising from $0.08 to $0.12. In the following year, the 0 analysts surveyed believe that Allient's Dividend per Share will decrease by 12.22%, reaching $0.11. According to professionals, by 2030, Allient's Dividend per Share will have decreased by 11.86%, falling down to $0.11.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MOG.A Stock Forecast | Moog | Outperform |
2
|
$162.22 | Buy/Sell | $150.33 | 4.80% |
| RSW Stock Forecast | Renishaw | Hold |
18
|
£41.20 | Buy/Sell | £34.00 | 6.19% |
| ICUI Stock Forecast | ICU Medical | Outperform |
16
|
$99.04 | Buy/Sell | $153.50 | 37.82% |
Allient EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Allient's EBITDA has seen an increase, rising from $39.45M to $69.28M. This represents a growth of 75.61%. Analysts predict that Allient's EBITDA will increase in the upcoming year, reaching $80.20M. This would represent an increase of 15.76%. Over the next seven years, experts predict that Allient's EBITDA will grow at a rate of 17.69%.
Allient EBIT Forecast for 2023 - 2025 - 2030
Allient's EBIT has seen growth In the last three years, going from $23.47M to $44.21M – a gain of 88.37% In the next year, analysts believe that EBIT will reach $47.95M – an increase of 8.46%. For the next seven years, the forecast is forEBIT to grow by 47.76%.
Allient EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Allient's EPS has decreased from $1.00 to $0.00 – a 100.00% drop. In the next year, analysts believe that EPS will reach $1.73 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
.jpg)